Medication info
Airosa Tablet 50 mg (Losartan Potassium)

Airosa Tablet 50 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Ari Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201907288 · Approved 2019.10.16 · Insurance code 058200450

Summary

Main use
Treatment of hypertension and nephropathy in patients with type 2 diabetes and hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is this medicine once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used blood glucose-lowering agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with reduced intravascular volume An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced intravascular volume (e.g., patients receiving diuretic therapy) (see Precautions for Use). 4) Patients with hepatic impairment Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
2) Children and adolescents aged 6 years and older (1) Patients weighing 20 kg or more and less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this medicine once daily, and may be increased up to a maximum of 50mg once daily depending on the patient's blood pressure response. (2) Patients weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, and may be increased up to a maximum of 100 mg once daily depending on the patient's blood pressure response. (3) Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Ingredients

Manufacturer
Ari Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and nephropathy in patients with type 2 diabetes and hypertension

  • Hypertension
  • kidney disease
View approved original text

This medication is used for the treatment of hypertension, particularly in patients with hypertension and type 2 diabetes, helping to prevent and manage kidney disease. Thus, it contributes to the overall health improvement of patients by controlling blood pressure and maintaining kidney health.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is this medicine once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used blood glucose-lowering agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with reduced intravascular volume An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced intravascular volume (e.g., patients receiving diuretic therapy) (see Precautions for Use). 4) Patients with hepatic impairment Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

2) Children and adolescents aged 6 years and older (1) Patients weighing 20 kg or more and less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this medicine once daily, and may be increased up to a maximum of 50mg once daily depending on the patient's blood pressure response. (2) Patients weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, and may be increased up to a maximum of 100 mg once daily depending on the patient's blood pressure response. (3) Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should not be used by women who are pregnant or may become pregnant. This medication should not be administered to patients with severely impaired liver function or certain genetic disorders. Use with caution in elderly patients or those with decreased kidney function and patients at risk of rapid drops in blood pressure; their condition should be regularly monitored during administration. During treatment, blood pressure, potassium levels, and kidney function should be regularly tested to check for abnormalities. If blood pressure drops too low or kidney function worsens, consult a doctor immediately; treatment may need to be halted if necessary. This medication can cause dangerously elevated potassium levels in the blood if taken with potassium-sparing diuretics or potassium supplements, so care should be taken not to use them together. It may interact with other medications, so consult a doctor or pharmacist especially if taking non-steroidal anti-inflammatory drugs (NSAIDs), lithium, or anticoagulants. During treatment with this medication, sudden dizziness or fainting may occur; caution should be exercised when driving or operating machinery. Women who are pregnant or breastfeeding should preferably not use this medication; if necessary, breastfeeding should be discontinued. This medication should not be administered to children, particularly those under the age of 6 or those with severely impaired kidney function. In the event of an overdose, symptoms such as low blood pressure and heart rhythm abnormalities may occur; contact a healthcare facility immediately for appropriate treatment. This medication should be stored out of reach of children, and it is safest not to transfer it to another container.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • low back pain
  • leg pain
  • dizziness
  • congestion
Show 131 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • indigestion
  • cough
  • sinus disorders
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • swelling
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm keratosis
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • dental pain
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • muscle weakness
  • shoulder pain
  • myotonia
  • arthralgia
  • arthritis
  • fibromyalgia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory loss
  • decreased libido
  • memory impairment
  • migraine
  • neurosensitization
  • sensory abnormalities
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • purpura
  • erythema
  • flushing
  • photosensitive reaction
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning
  • ocular pain
  • conjunctivitis
  • taste disorder
  • tinnitus
  • visual impairment
  • erectile dysfunction
  • nocturia
  • frequent urination
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • liver dysfunction
  • hepatitis
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • myalgia
  • malaise
  • elevated creatine kinase
  • rhabdomyolysis
  • dry cough
  • erythema annulare
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopy
  • hypoglycemia
  • shock symptoms due to hypotension
  • loss of consciousness
  • vomiting
  • increased serum creatinine
  • decreased hemoglobin
  • decreased hematocrit

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to maintain the storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.